These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9923535)

  • 61. High-dose epirubicin in combination with cyclophosphamide (HD-EC) in advanced breast cancer: final results of a dose finding study and phase II trial.
    Marschner N; Nagel GA; Beyer JH; Adler M; Ammon A
    Onkologie; 1990 Aug; 13(4):272-8. PubMed ID: 2234780
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.
    Williams SF; Gilewski T; Mick R; Bitran JD
    J Clin Oncol; 1992 Nov; 10(11):1743-7. PubMed ID: 1357109
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients.
    Meinardi MT; van Veldhuisen DJ; Gietema JA; Dolsma WV; Boomsma F; van den Berg MP; Volkers C; Haaksma J; de Vries EG; Sleijfer DT; van der Graaf WT
    J Clin Oncol; 2001 May; 19(10):2746-53. PubMed ID: 11352968
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells.
    Hempel P; Müller P; Oruzio D; Behr W; Brockmeyer C; Wochner M; Ehnle S; Riethmüller R; Schlimok G
    Cytotherapy; 2000; 2(4):287-95. PubMed ID: 12042038
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.
    Ryberg M; Nielsen D; Skovsgaard T; Hansen J; Jensen BV; Dombernowsky P
    J Clin Oncol; 1998 Nov; 16(11):3502-8. PubMed ID: 9817267
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epirubicin: a review of its efficacy as adjuvant therapy and in the treatment of metastatic disease in breast cancer.
    Ormrod D; Holm K; Goa K; Spencer C
    Drugs Aging; 1999 Nov; 15(5):389-416. PubMed ID: 10600046
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer.
    Williams SF; Mick R; Desser R; Golick J; Beschorner J; Bitran JD
    J Clin Oncol; 1989 Dec; 7(12):1824-30. PubMed ID: 2511276
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical impacts of tumor cell contamination of hematopoietic stem cell products in metastatic breast cancer patients undergoing autologous peripheral blood stem cell transplantation: multicenter trial.
    Ahn MJ; Noh YH; Lee YS; Lee YY; Choi IY; Kim IS; Joh EK; Shin DB; Kim SY; Cho KS; Kim HC; Kim HS; Suh CW; Kim SH; Lee JA; Park YS
    J Korean Med Sci; 2001 Apr; 16(2):175-82. PubMed ID: 11306743
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer.
    McCauley DL
    Am J Health Syst Pharm; 1996 Mar; 53(5):521-34; quiz 561-2. PubMed ID: 8697012
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer.
    Peters WP; Dansey RD; Klein JL; Baynes RD
    Oncologist; 2000; 5(1):1-13. PubMed ID: 10706643
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer.
    Tokuda Y; Ohta M; Okumura A; Kuge S; Kubota M; Tajima T; Mitomi T
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S94-9. PubMed ID: 9272142
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Neo-adjuvant chemotherapy for breast cancer].
    Shi J; Fang G; Sheng Y
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):423-5. PubMed ID: 11810778
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer.
    Eddy DM
    J Clin Oncol; 1992 Apr; 10(4):657-70. PubMed ID: 1285731
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Feasibility and long-term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinoma.
    Airoldi M; De Crescenzo A; Pedani F; Marchionatti S; Gabriele AM; Succo G; Rosti G; Bumma C
    Head Neck; 2001 Sep; 23(9):799-803. PubMed ID: 11505492
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescue.
    Carter DL; Marks LB; Bean JM; Broadwater G; Hussein A; Vredenburgh JJ; Peters WP; Prosnitz LR
    J Clin Oncol; 1999 Mar; 17(3):887-93. PubMed ID: 10071280
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer.
    Benedetti-Panici P; Greggi S; Scambia G; Salerno MG; Menichella G; Pierelli L; Foddai ML; Bizzi B; Mancuso S
    Ann Med; 1995 Feb; 27(1):133-8. PubMed ID: 7741993
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative Group.
    Vermorken JB; Kobierska A; Chevallier B; Zanaboni F; Pawinski A; Bolis G
    Ann Oncol; 2000 Aug; 11(8):1035-40. PubMed ID: 11038042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.
    Fountzilas G; Nicolaides C; Aravantinos G; Skarlos D; Kosmidis P; Papakostas P; Stathopoulos GP; Kontostolis E; Bafaloukos D; Pavlidis N
    Oncology; 1998; 55(6):508-12. PubMed ID: 9778614
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epirubicin: is it like doxorubicin in breast cancer? A clinical review.
    Khasraw M; Bell R; Dang C
    Breast; 2012 Apr; 21(2):142-9. PubMed ID: 22260846
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.
    Michelotti A; Venturini M; Tibaldi C; Bengala C; Gallo L; Carnino F; Del Mastro L; Lionetto R; Montanaro E; Rosso R; Conte P
    Breast Cancer Res Treat; 2000 Jan; 59(2):133-9. PubMed ID: 10817348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.